International Psoriasis Council

Advancing Knowledge. Enhancing Care.

Advancing Knowledge. Enhancing Care.

Psoriasis News

THE LATEST FROM IPC, INDUSTRY, AND NEWS

Results
World Psoriasis Day blog image

World Psoriasis Day

Biologics and biosimilars have created many new options in psoriasis treatment for patients worldwide, but patients worldwide face barriers to acquiring them. This has led IPC Councilor Dr. Matias Maskin to reconsider what success means for psoriasis patients.

Read More

Commentary: Psoriasis comprehensive review

In the April 2021 issue of the Lancet, four of our esteemed colleagues in the IPC published an updated and comprehensive review of the current pieces of knowledge on psoriasis. It is a very well-written review covering all aspects of psoriasis

Read More

New IPC councilor

Satveer Mahil joins the group of respected IPC psoriasis experts who are working to advance knowledge and enhance the care of psoriasis patients.

Read More
computer with words expert commentary

Commentary: Genetic studies suggest that inflammatory skin diseases increase the risk of COVID-19

An article recently published in the Journal of Allergy and Clinical Immunology suggests that diseases such as psoriasis and atopic dermatitis increase the risk of COVID-19 by approximately 50%. The authors of the study (Lam Tsoi and collaborators, University of Michigan) examined the medical records of 435,000 individuals, 1,115 of whom had been diagnosed with COVID-19.

Read More

In the Lab with IPC Councilor Nicole Ward

Dr. Ward is a Professor of Dermatology and Neurosciences at Case Western Reserve University and University Hospitals Case Medical Center in Cleveland, Ohio. She has spent the past 16 years

Read More
think tank 2020 blog image

2020 Virtual Think Tank Meeting Report

Held virtually on December 11 due to the Coronavirus Pandemic, the 2020 IPC Think Tank convened more than 100 specialists in psoriasis and industry partners from all over the world to discuss the most pressing issues affecting psoriasis care and treatment globally. The outcome of these discussions will inform IPC initiatives in 2021 and beyond.

Read More
computer with words expert commentary

Commentary: NPF COVID-19 Task Force Guidance Statements

Recently, the Task Force (TF) of the National Psoriasis Foundation (NPF) released a revised version of its COVID-19 statement after an in-depth analysis of publicly available data with two currently approved anti-SARS-CoV-2 vaccines in the US, both mRNA-based.

Read More

New Resources

Roflumilast – A Potential New First Line Systemic Drug for Psoriasis

Focus on Psoriasis: A Report from the European Academy of Dermatology and Venereology 31st Annual Congress (EADV)

La perspectiva del paciente

Subscribe to the IPC Newsletter

We believe that psoriasis patients, no matter where they live in the world, no matter how complex their symptoms, should have access to the best care available to them. Please join us in making this possible.